|
⚲
|
| Keyboard |
| John Ryals | |
|---|---|
| Firm | |
| Address | 565 Metro Place South, Suite 3039 Dublin, OH 43017 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Biosortia Pharmaceuticals Inc | 021-352675 | Director | 0.7 M of 3.7 M |
||
| Metabolon Inc | 021-347484 | Director | 7.8 M of 9.0 M |
||
| Phytelligence Inc | 021-324431 | Director | 2.5 M of 10.0 M |
||
| Metabolon Inc | 021-320288 | Director | 7.3 M of 8.3 M |
||
| Agbiome LLC | 021-317048 | Director | 65.0 M of 65.0 M |
||
| Muses Labs Inc | 021-290175 | Director | 2.1 M of 5.8 M |
||
| Metabolon Inc | 021-269590 | Executive Officer | 30.0 M of 30.0 M |
||
| Agbiome LLC | 021-246215 | Director | 34.5 M of 34.5 M |
||
| Phytelligence Inc | 021-243379 | Director | 16.8 M of 20.0 M |
||
| Metabolon Inc | 021-235734 | Executive Officer | 5.0 M of 5.0 M |
||
| Metabolon Inc | 021-208960 | Executive Officer | 15.0 M of 15.0 M |
||
| Metabolon Inc | 021-165464 | Executive Officer | 13.2 M of 13.2 M |
||
| Metabolon Inc | 021-53696 | Executive Officer | 6.1 M of 6.1 M |
||